Todd Bazemore's Insider Trades & SAST Disclosures
Todd Bazemore's most recent trade in Kala Pharmaceuticals Inc was a trade of 45,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Todd Bazemore.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 45,200 | 45,200 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 45,200 | 45,200 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,100 | - | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 7.63 per share. | 06 Jan 2025 | 1,993 | - | 0% | 7.6 | 15,207 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 26 Jun 2024 | 4,653 | 83,040 (0%) | 0% | 4.8 | 22,102 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.09 per share. | 31 May 2024 | 2,093 | 87,693 (0%) | 0% | 6.1 | 12,746 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 29,300 | 29,300 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Bazemore Todd | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 6,500 | - | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Bazemore Todd | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 04 Jan 2024 | 1,405 | - | 0% | 6.7 | 9,470 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 576 | 576 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Todd Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 1,700 | 1,700 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 12,800 | 14,897 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 04 Jan 2023 | 62 | 14,835 (0%) | 0% | 28.5 | 1,769 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.51 per share. | 26 Oct 2022 | 214 | 2,097 (0%) | 0% | 6.5 | 1,393 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 27 Jun 2022 | 3,092 | 115,499 (0%) | 0% | 0.4 | 1,144 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 238,000 | 238,000 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 03 Jan 2022 | 3,454 | 118,591 (0%) | 0% | 1.3 | 4,490 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 26 Oct 2021 | 12,544 | 122,045 (0%) | 0% | 1.8 | 22,579 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 5.77 per share. | 28 Jun 2021 | 2,911 | - | 0% | 5.8 | 16,796 | Common Stock |
| Pulmatrix Inc | Todd Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 27,500 | 137,500 (0%) | 0% | 0 | Common Stock | |
| Pulmatrix Inc | Todd Bazemore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 19,000 | 29,000 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 81,000 | 110,000 (0%) | 0% | 0 | Common Stock | |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 7.60 per share. | 05 Jun 2020 | 40 | 42 (0%) | 0% | 7.6 | 304 | Common Stock |
| Kala Pharmaceuticals Inc | Todd Bazemore | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 05 Jun 2020 | 2 | 2 (0%) | 0% | 13.5 | 27 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges